These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28578024)

  • 1. Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.
    Taylor RP; Lindorfer MA; Cook EM; Beurskens FJ; Schuurman J; Parren PWHI; Zent CS; VanDerMeid KR; Burack R; Mizuno M; Morgan BP
    Clin Immunol; 2017 Aug; 181():24-28. PubMed ID: 28578024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.
    Cook EM; Lindorfer MA; van der Horst H; Oostindie S; Beurskens FJ; Schuurman J; Zent CS; Burack R; Parren PW; Taylor RP
    J Immunol; 2016 Sep; 197(5):1762-75. PubMed ID: 27474078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity.
    Saar Ray M; Moskovich O; Iosefson O; Fishelson Z
    J Biol Chem; 2014 May; 289(21):15014-22. PubMed ID: 24719326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.
    Oostindie SC; van der Horst HJ; Lindorfer MA; Cook EM; Tupitza JC; Zent CS; Burack R; VanDerMeid KR; Strumane K; Chamuleau MED; Mutis T; de Jong RN; Schuurman J; Breij ECW; Beurskens FJ; Parren PWHI; Taylor RP
    Haematologica; 2019 Sep; 104(9):1841-1852. PubMed ID: 30792198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
    Zalman LS; Müller-Eberhard HJ
    Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
    Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW
    Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells.
    Lindorfer MA; Cook EM; Tupitza JC; Zent CS; Burack R; de Jong RN; Beurskens FJ; Schuurman J; Parren PW; Taylor RP
    Mol Immunol; 2016 Feb; 70():13-23. PubMed ID: 26690706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
    Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
    J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement.
    Baig NA; Taylor RP; Lindorfer MA; Church AK; Laplant BR; Pavey ES; Nowakowski GS; Zent CS
    Leuk Lymphoma; 2012 Nov; 53(11):2218-27. PubMed ID: 22475085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does complement kill E. coli by producing transmural pores?
    Born J; Bhakdi S
    Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL.
    Middleton O; Cosimo E; Dobbin E; McCaig AM; Clarke C; Brant AM; Leach MT; Michie AM; Wheadon H
    Leukemia; 2015 Jan; 29(1):107-14. PubMed ID: 24787488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of complement C5b-9 binding to cells by flow cytometry.
    Moskovich O; Fishelson Z
    Methods Mol Biol; 2014; 1100():103-8. PubMed ID: 24218253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.